Using a stool test to predict varices in cirrhosis
Part of Digestive system clinical trials.
This study checks if a simple stool test (fecal calprotectin) can help predict the presence of enlarged veins in the esophagus (varices) in people with cirrhosis. If successful, this could offer a non-invasive way to screen for this serious complication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have a diagnosis of liver cirrhosis.
- You do not have inflammatory bowel disease (like Crohn's disease or ulcerative colitis).
- You do not have an active infection of the stomach or intestines.
- You are not currently being treated for any type of cancer.
- You are not taking medications called proton pump inhibitors (like omeprazole) or NSAIDs (like ibuprofen).
- You do not have spontaneous bacterial peritonitis (an infection in the belly fluid).
- You do not have hepatic encephalopathy (confusion caused by liver problems).
- You are willing to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether ultrasound imaging can predict which patients with cirrhosis (scarring of the liver) are at higher risk of dangerous bleeding from enlarged veins in the esophagus. If successful, this could help doctors decide which patients need preventive treatment.
This study tests if non-invasive methods like blood tests and spleen size can predict esophageal varices in children with portal hypertension, potentially reducing the need for endoscopy.
This study tests a new ultrasound method that measures spleen stiffness to help diagnose swollen veins in the esophagus (called esophageal varices) in people with chronic liver disease. If these veins are found early, it could help prevent dangerous bleeding.
This study looks at how to best use endoscopy and other procedures to stop bleeding from enlarged veins in the esophagus or stomach caused by liver disease. It aims to find the safest and most effective treatment approach for people with this condition.
This trial compares two approaches to prevent future bleeding from enlarged veins in the esophagus (food pipe) in patients with liver cirrhosis who have already had one bleeding episode. You'll receive either an endoscopic procedure with medication or a minimally invasive vein procedure, to see which works better long-term.
This trial studies better ways to use endoscopy and other treatments to stop bleeding in the stomach or esophagus caused by high blood pressure in the liver (portal hypertension). It may help if you have been diagnosed with portal hypertension and have varices (enlarged veins) in your esophagus or stomach.
Hear when a new Esophageal Varices trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.